Morris Karmazyn

1.2k total citations
38 papers, 955 citations indexed

About

Morris Karmazyn is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Morris Karmazyn has authored 38 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 12 papers in Physiology. Recurrent topics in Morris Karmazyn's work include Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Morris Karmazyn is often cited by papers focused on Cardiac Ischemia and Reperfusion (15 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Morris Karmazyn collaborates with scholars based in Canada, United States and Japan. Morris Karmazyn's co-authors include Jianmin Duan, Naranjan S. Dhalla, Venkatesh Rajapurohitam, Asraul Hoque, Subrata Chakrabarti, Daniel M. Purdham, Asad Zeidan, Mary Murphy, M Horácková and Robert E. Beamish and has published in prestigious journals such as The FASEB Journal, Journal of Applied Physiology and Critical Care Medicine.

In The Last Decade

Morris Karmazyn

37 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morris Karmazyn Canada 16 372 354 283 242 102 38 955
Katalin Komjáti Hungary 18 311 0.8× 246 0.7× 140 0.5× 345 1.4× 94 0.9× 30 1.3k
Carlo Duilio Italy 10 397 1.1× 295 0.8× 433 1.5× 234 1.0× 115 1.1× 24 1.1k
Karen P. Burton United States 14 351 0.9× 348 1.0× 443 1.6× 172 0.7× 73 0.7× 22 1.0k
Adrian Gonon Sweden 24 329 0.9× 480 1.4× 293 1.0× 585 2.4× 184 1.8× 39 1.3k
Ľudmila Okruhlicová Slovakia 23 524 1.4× 453 1.3× 119 0.4× 269 1.1× 158 1.5× 68 1.2k
Viktoriya Solodushko United States 16 454 1.2× 236 0.7× 231 0.8× 388 1.6× 77 0.8× 25 1.1k
Nelson Escobales Puerto Rico 14 521 1.4× 229 0.6× 156 0.6× 251 1.0× 95 0.9× 49 968
Nicola Di Venosa Italy 10 814 2.2× 164 0.5× 456 1.6× 222 0.9× 79 0.8× 13 1.3k
Richard B. Wambolt Canada 21 748 2.0× 749 2.1× 363 1.3× 425 1.8× 278 2.7× 30 1.5k
J. T. Povlishock India 10 266 0.7× 213 0.6× 122 0.4× 435 1.8× 56 0.5× 13 1.1k

Countries citing papers authored by Morris Karmazyn

Since Specialization
Citations

This map shows the geographic impact of Morris Karmazyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Karmazyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Karmazyn more than expected).

Fields of papers citing papers by Morris Karmazyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morris Karmazyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Karmazyn. The network helps show where Morris Karmazyn may publish in the future.

Co-authorship network of co-authors of Morris Karmazyn

This figure shows the co-authorship network connecting the top 25 collaborators of Morris Karmazyn. A scholar is included among the top collaborators of Morris Karmazyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morris Karmazyn. Morris Karmazyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karmazyn, Morris & Xiaohong Tracey Gan. (2018). Ginseng for the treatment of diabetes and diabetes-related cardiovascular complications: a discussion of the evidence. Canadian Journal of Physiology and Pharmacology. 97(4). 265–276. 9 indexed citations
2.
3.
Chen, Ling, Zhang Jin, Ye Chen‐Izu, et al.. (2007). Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. Journal of Applied Physiology. 104(1). 218–223. 74 indexed citations
4.
Sathish, Venkatachalem, Alex Xu, Morris Karmazyn, Stephen M. Sims, & Njanoor Narayanan. (2006). Mechanistic basis of differences in Ca2+-handling properties of sarcoplasmic reticulum in right and left ventricles of normal rat myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 291(1). H88–H96. 20 indexed citations
5.
Avkiran, Metin, Morris Karmazyn, & Larry Fliegel. (2003). The Sodium-Hydrogen Exchanger: From Molecule to its Role in Disease. Medical Entomology and Zoology. 9 indexed citations
6.
Gazmuri, Raúl J., Iyad M. Ayoub, Julieta D Kolarova, & Morris Karmazyn. (2002). Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Critical Care Medicine. 30(Supplement). S166–S171. 22 indexed citations
7.
Karmazyn, Morris. (2000). Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases. Expert Opinion on Investigational Drugs. 9(5). 1099–1108. 35 indexed citations
8.
Ward, Christopher A., M. P. Moffat, & Morris Karmazyn. (1996). Signal transduction mechanisms in the ischemic and reperfused myocardium. Birkhäuser Basel eBooks. 76. 191–207. 5 indexed citations
9.
Karmazyn, Morris, et al.. (1996). Inhibition of β- but not a α1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Cardiovascular Research. 32(3). 622–629. 6 indexed citations
10.
Khandoudi, Nassirah, et al.. (1994). Adenosine‐sensitive α1‐adrenoceptor effects on reperfused ischaemic hearts: comparison with phorbol ester. British Journal of Pharmacology. 112(4). 1007–1016. 13 indexed citations
11.
Duan, Jianmin & Morris Karmazyn. (1990). Reduction of phosphate-induced dysfunction in rat heart mitochondria by carnitine. European Journal of Pharmacology Molecular Pharmacology. 189(2-3). 163–174. 5 indexed citations
12.
Duan, Jianmin & Morris Karmazyn. (1990). Protection of the Reperfused Ischemic Isolated Rat Heart by Phosphatidylcholine. Journal of Cardiovascular Pharmacology. 15(1). 163–171. 10 indexed citations
13.
Karmazyn, Morris. (1989). Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion. Canadian Journal of Physiology and Pharmacology. 67(8). 912–921. 38 indexed citations
14.
15.
16.
Karmazyn, Morris. (1986). Contribution of prostaglandins to reperfusion-induced ventricular failure in isolated rat hearts. American Journal of Physiology-Heart and Circulatory Physiology. 251(1). H133–H140. 48 indexed citations
17.
Beamish, Robert E., P. K. Das, Morris Karmazyn, & Naranjan S. Dhalla. (1985). Prostaglandins and heart disease.. PubMed. 1(1). 66–74. 9 indexed citations
18.
Karmazyn, Morris & Naranjan S. Dhalla. (1983). Physiological and pathophysiological aspects of cardiac prostaglandins. Canadian Journal of Physiology and Pharmacology. 61(11). 1207–1225. 70 indexed citations
19.
Karmazyn, Morris, M. P. Moffat, Robert E. Beamish, & N. S. Dhalla. (1981). Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.. Journal of Pharmacology and Experimental Therapeutics. 218(3). 764–770. 9 indexed citations
20.
Karmazyn, Morris, Robert E. Beamish, Larry Fliegel, & Naranjan S. Dhalla. (1981). Adrenochrome-induced coronary artery constriction in the rat heart.. Journal of Pharmacology and Experimental Therapeutics. 219(1). 225–230. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katalin Komjáti Breakdown of academic impact, for papers by Carlo Duilio Breakdown of academic impact, for papers by Karen P. Burton Breakdown of academic impact, for papers by Adrian Gonon Breakdown of academic impact, for papers by Ľudmila Okruhlicová Breakdown of academic impact, for papers by Viktoriya Solodushko Breakdown of academic impact, for papers by Nelson Escobales Breakdown of academic impact, for papers by Nicola Di Venosa Breakdown of academic impact, for papers by Richard B. Wambolt Breakdown of academic impact, for papers by J. T. Povlishock
Rankless by CCL
2026